Synonyms: deuremidevir | JT001 | Mindavi® | VV-116 | VV116 | X6 hydrobromide [PMID: 34584244]
mindeudesivir is an approved drug (China NMPA (2023))
Compound class:
Synthetic organic
Comment: VV116 is an orally available, deuterated remdesivir analogue [6-7]. It is a tri-isobutyrate ester prodrug (formulated as the hydrobromide salt) that is converted to an active nucleoside triphosphate (116-NTP) that acts as a viral RNA-dependent RNA polymerase (RdRP) inhibitor. VV116 was developed for antiviral activity against SARS-CoV-2. We drew the chemical structure as represented in Xie et al. (2021) [6]. The chemical structure for VV116 was later matched to that for the INN mindeudesivir.
|
|
Bioactivity Comments |
116-NTP inhibits SARS-CoV-2 RdRp with an IC50 of 670 nM in a biochemical enzyme activity assay [6]. The prodrug V116 inhibits SARS-CoV-2 replication with an EC50 of 350 nM in a Vero E6 cell infection assay. The compound also inhibits replication of RSV in a HEp-2 cell infection assay [4]. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|